Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page history now shows Revision: v3.6.6 as the latest update and removes Revision: v3.6.5.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision tag (v3.6.5) was added, indicating a platform update without altering the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a minor update to the page's version. This reflects an internal update to the page infrastructure rather than any change to the study details.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, signaling a refresh of the page's template or related metadata rather than a substantive change to study details.SummaryDifference0.0%

- Check86 days agoChange DetectedA recruitment status line 'No longer looking for participants' has been added, indicating enrollment is closed, and new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') have been introduced. The 'Intervention / Treatment' heading has been updated to 'Intervention/Treatment' and the page revision is updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check94 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This update appears to be a maintenance revision rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.